Cibc World Market Inc. Novo Nordisk A S Transaction History

Cibc World Market Inc.

  • $47.7 Billion
  • Q4 2024

A detailed history of Cibc World Market Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Cibc World Market Inc. holds 658,463 shares of NVO stock, worth $59.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
658,463
Previous 619,774 6.24%
Holding current value
$59.7 Million
Previous $73.8 Million 23.25%
% of portfolio
0.12%
Previous 0.15%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
BUY
$85.0 - $120.04 $3.29 Million - $4.64 Million
38,689 Added 6.24%
658,463 $56.6 Million
Q3 2024

Nov 12, 2024
BUY
$119.07 - $145.42 $14.3 Million - $17.5 Million
120,378 Added 24.1%
619,774 $73.8 Million
Q2 2024

Aug 07, 2024
BUY
$122.71 - $146.91 $13.9 Million - $16.6 Million
113,136 Added 29.29%
499,396 $71.3 Million
Q1 2024

May 13, 2024
BUY
$102.11 - $135.92 $3.66 Million - $4.87 Million
35,810 Added 10.22%
386,260 $49.6 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $971,724 - $1.17 Million
-11,070 Reduced 3.06%
350,450 $36.3 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $17 Million - $37.4 Million
187,350 Added 107.57%
361,520 $32.9 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $1.86 Million - $2.06 Million
-11,934 Reduced 6.41%
174,170 $28.2 Million
Q1 2023

May 12, 2023
BUY
$132.34 - $159.14 $4.19 Million - $5.04 Million
31,647 Added 20.49%
186,104 $29.6 Million
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $4.38 Million - $5.78 Million
42,729 Added 38.24%
154,457 $20.9 Million
Q3 2022

Nov 10, 2022
SELL
$95.28 - $116.93 $3.43 Million - $4.2 Million
-35,955 Reduced 24.35%
111,728 $11.1 Million
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $1.42 Million - $1.68 Million
13,773 Added 10.29%
147,683 $16.5 Million
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $1.62 Million - $1.96 Million
-17,405 Reduced 11.5%
133,910 $14.9 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $257,725 - $314,711
-2,688 Reduced 1.75%
151,315 $16.9 Million
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $3.11 Million - $3.93 Million
36,833 Added 31.44%
154,003 $14.8 Million
Q2 2021

Aug 12, 2021
SELL
$67.66 - $84.76 $422,469 - $529,241
-6,244 Reduced 5.06%
117,170 $9.82 Million
Q1 2021

May 11, 2021
BUY
$67.06 - $75.82 $1.31 Million - $1.48 Million
19,539 Added 18.81%
123,414 $8.32 Million
Q4 2020

Feb 08, 2021
BUY
$63.89 - $73.8 $863,345 - $997,259
13,513 Added 14.95%
103,875 $7.26 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $289,025 - $318,658
-4,538 Reduced 4.78%
90,362 $6.27 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $3.19 Million - $3.7 Million
-54,477 Reduced 36.47%
94,900 $6.21 Million
Q1 2020

May 15, 2020
SELL
$49.46 - $64.78 $802,191 - $1.05 Million
-16,219 Reduced 9.79%
149,377 $8.99 Million
Q4 2019

Feb 13, 2020
BUY
$49.86 - $58.26 $350,565 - $409,626
7,031 Added 4.43%
165,596 $9.59 Million
Q3 2019

Nov 13, 2019
SELL
$47.54 - $53.43 $274,400 - $308,397
-5,772 Reduced 3.51%
158,565 $8.2 Million
Q2 2019

Aug 08, 2019
SELL
$46.79 - $52.47 $1.08 Million - $1.21 Million
-23,062 Reduced 12.31%
164,337 $8.39 Million
Q1 2019

May 09, 2019
BUY
$46.36 - $52.63 $2.82 Million - $3.2 Million
60,811 Added 48.04%
187,399 $9.8 Million
Q4 2018

Feb 13, 2019
BUY
$41.54 - $47.25 $192,870 - $219,381
4,643 Added 3.81%
126,588 $5.83 Million
Q3 2018

Nov 09, 2018
BUY
$46.76 - $51.24 $359,724 - $394,189
7,693 Added 6.73%
121,945 $5.75 Million
Q2 2018

Aug 08, 2018
BUY
$44.29 - $50.42 $336,736 - $383,343
7,603 Added 7.13%
114,252 $5.27 Million
Q1 2018

May 18, 2018
BUY
$48.49 - $58.14 $5.17 Million - $6.2 Million
106,649 New
106,649 $5.25 Million

Others Institutions Holding NVO

# of Institutions
1,884
Shares Held
336M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $205B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email